Posted on 02/17/2021 7:58:43 PM PST by SeekAndFind
Two COVID-19 vaccines are available in the U.S., and a third, developed by Johnson & Johnson recently submitted an application for emergency use authorization, meaning it could be available in early March.
With so many options, many people are wondering whether it matters which shot they get.
The short answer is that you should get whichever shot you are offered, experts told Live Science. But there are several reasons why certain shots might work better for different populations.
The Johnson & Johnson vaccine had 66% efficacy at reducing severe and moderate cases of COVID-19, which include either two mild symptoms or one more serious symptom, such as low blood oxygen levels or increased respiratory rate, Live Science previously reported. In other words, people vaccinated with the J&J shot were three times less likely to get a mild or moderate case of COVID-19 compared with participants who received a placebo. Meanwhile, the Pfizer/BioNTech vaccine had 95% efficacy, and the Moderna vaccine had 94% efficacy at preventing symptomatic COVID-19, meaning any positive test with even one symptom, however mild.
All three vaccines are thought to be 100% effective at preventing hospitalization and death related to COVID-19.
But while the Moderna and Pfizer two-shot regimens look, on paper, to be more efficacious, the Johnson & Johnson vaccine has an edge because it doesn't require a follow-up shot and it can be stored at ordinary refrigerator temperatures for months, said Dr. Peter Gulick, a professor of medicine and an infectious disease expert at Michigan State University College of Osteopathic Medicine. That could help with getting more people vaccinated especially those who may not come back for a second shot, as well as in locales where access is a problem, he said.
(Excerpt) Read more at foxnews.com ...
Russian roulette
With the rise of new coronavirus variants, some protection is better than no protection. Because a one-shot vaccine such as Johnson & Johnson’s only requires one shot, the same number of doses can go twice as far as with the other vaccines, which might be better for controlling the spread of the virus.
However, initial supply of the J&J vaccine will be limited; the company initially promised 12 million doses in March, but it may fall behind on production, according to The New York Times.
Dr. William Lang, former White House physician and the medical director of JobSiteCare, told Live Science that the lower efficacy shouldn’t dissuade people from getting the Johnson & Johnson vaccine. Unlike Pfizer and Moderna, Johnson & Johnson tested their vaccine against the South African variant, which has been shown to evade neutralizing antibodies, which the immune system deploys to stop the coronavirus from infecting cells.
“The reported lower effectiveness may be somewhat real, but it may also be a function of testing in a slightly different environment because of the newly circulating variants,” Lang said. “If my 88-year-old dad or I were offered J&J, I would not hesitate to get it.”
Given the emergence of vaccine-evading variants, like the South African and Brazilian variants, reducing spread as quickly as possible is necessary to lower the chances for further mutations to evolve, Gulick said.
I will take old and safe, one shot, no need for crispy coolers....any day of the week.
completely untrue
The J&J vaccine is produced traditionally with messing with RNA.
Do not take the damn vaccine.
All the wrong entities are desperate for you to do so.
Ask yourself why ?
bump to the top
By law, if there is a treatment that is effective then the Emergency Use Authorization (should be withdrawn).
Remdesivir (is approved for treatment)
Ivermectin is the ticket.
It worked like a champ for me.
Congrats! You’ve given the world proof that not all conservatives are smart.
It’s also not an mRNA frankenvaccine.
I’ll wait until they get it all sorted out. I’ll be 74 this year, and haven’t been socially active since I retired in 2003. I live alone, and besides doctor appointments, grocery shopping about once a week, and visiting my two sons, my sister-in-law (my brother’s widow), and their family, I don’t go anywhere else. I have a very small circle of people I interact with. My niece (my brother’s daughter runs a lab in a Rochester, NY hospital, and got both shots. She said she didn’t have any problem with the first one, but the second one made her sicker than a dog. I’m headed out tomorrow to spend the next four days with them. They were last here in October.
Are there any experts who can explain why the CDC is recommending that those who have had COVID-19 clinical infections should still receive the mRNA vaccines? Not sure why the CDC makes this recommendation since actual re-infection with COVID-19 has been extremely rare. Not aware of any studies that suggest that people who have COVID -19 antibodies are even susceptible to the so called variants.
Where did you get it?
All the more reason to wait it out and let others be the guinea pigs.
Even if all are basically safe and effective (but for how long????), some could prove better or worse for certain types of people.
Nope, not gonna do it. It’ll be at least a year before I let any of us here get any.
But I’m hearing now from some people - and my niece who works in Hopkins COVID - that generally the antibodies only last 3 months.
We all had it so we’re officially to run out of “immunity” soon, if that is the case.
The other question is: HOW LONG DOES THE IMMUNITY LAST FROM THESE THINGS?
How much ivermectin did you take and where did you get it?
Your opinion.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.